v3.22.2.2
Condensed Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:        
Net loss $ (4,244) $ (3,141) $ (11,276) $ (6,194)
Adjustments to reconcile net loss to net cash used in operating activities:        
Stock-based compensation     2,123 702
Depreciation and amortization 386 441 1,116 1,068
Non-cash operating lease expense     417 0
Gain on forgiveness of PPP loan and other     24 (743)
Changes in operating assets and liabilities:        
Accounts receivable     (520) (465)
Inventories     (3) 286
Prepaid expenses and other current assets     (2,206) 38
Deferred costs     73 (1,020)
Accounts payable     2,275 (1,837)
Accrued and other current liabilities     425 380
Deferred revenue     (282) 1,478
Operating lease liabilities     (350) 0
Net cash used in operating activities     (8,184) (6,307)
Cash flows from investing activities:        
Purchase of property and equipment     (747) (276)
Net cash used in investing activities     (747) (276)
Cash flows from financing activities:        
Proceeds from exercise of stock options     8 1
Proceeds from issuance of common stock in connection with business combination and PIPE investment, net of issuance costs     71,090 0
Capital contributions from Amprius Holdings     505 19,692
Payment of costs in connection with a stock purchase agreement     (25) 0
Net cash provided by financing activities     71,578 19,693
Net increase in cash and cash equivalents     62,647 13,110
Cash, cash equivalents, and restricted cash, beginning of period     11,489 2
Cash, cash equivalents, and restricted cash, end of period 74,136 13,112 74,136 13,112
Components of cash, cash equivalents, and restricted cash:        
Cash and cash equivalents 73,803 13,112 73,803 13,112
Restricted cash included in other assets 333 0 333 0
Total cash, cash equivalents, and restricted cash $ 74,136 $ 13,112 $ 74,136 $ 13,112

Source